Impaired phagocyte oxidative capacity in patients with human immunodeficiency virus infection

Journal of Laboratory and Clinical Medicine

Volumn 132, Issue 4, 1998, Pages 284-293

  Pitrak, David L ^a   Mullane, Kathleen M ^b   Bilek, Michelle L ^b   Stevens, Paul ^b   Allen, Robert C ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032191957     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(98)90041-5     Document Type: Article

References (37)

1. Lehrer RI, Ganz T, Selsted ME, Babior BM, Curnutte JT. Neutrophils and host defense. Ann Intern Med 1988;109:127-42.
2. Sawyer DW, Donowitz GR, Mandell GL. Polymorphonuclear neutrophils: an effective antimicrobial force. Rev Infect Dis 1989;11(supp17):S1532-44.
3. Johnston RB Jr. Current concepts: immunology. Monocytes and macrophages. N Engl J Med 1988;318:747-52.
4. Klebanoff SJ, Coombs RW. Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1. Role of myeloperoxidase system. J Clin Invest 1992;89:2014-107.
5. Szelc CM, Mitcheltree C, Roberts RL, Stiehm ER. Deficient polymorphonuclear cell and mononuclear cell antibody-dependent cellular cytotoxicity in pediatric and adult human immunodeficiency virus infection. J Infect Dis 1992;166:486-93.
6. Baldwin GC, Fuller ND, Roberts RL, Ho DD, Golde DW. Granulocyte- and granulocyte-macrophage colony-stimulating factors enhance neutrophil cytotoxicity toward HIV-infected cells. Blood 1989;74:1673-7.
7. Longo N, Zabay JM, Sempere JM, Navarro J, Fernandez-Cruz E. Altered production of PGE2, IL-1 beta and TNF-alpha by peripheral blood monocytes from HIV-positive individuals at early stages of HIV infection. J Acquir Immune Defic Syndr 1993;6:1017-23.
8. Blauvelt A, Clerici M, Lucey DR, Steinberg SM, Yarchoan R, Walker R, et al. Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons. J Immunol 1995;154:3506-15.
9. Bandres JC, Trial J, Musher DM, Rossen RD. Increased phagocytosis and generation of reactive oxygen products by neutrophils and monocytes of men with stage 1 human immunodeficiency virus infection. J Infect Dis 1993;168:75-83.
10. Trial J, Birdsall HH, Hallum JA, Crane ML, Rodriquez-Barradas MC, de Jong AL, et al. Phenotypic and functional changes in peripheral blood monocytes during progression of human immunodeficiency virus infection. Effects of soluble immune complexes, cytokines, subcellular paticulates from apoptotic cells, and HIV-1-encoded proteins on monocytes phagocytic function, oxidative burst, transendothelial migration, and cell surface phenotype. J Clin Invest 1995;95:1690-701.
11. Chen TP, Roberts RL, Wu KG, Ank BJ, Stiehm ER. Decreased Superoxide anion and hydrogen peroxide production by neutrophils and monocytes in human immunodeficiency virus-infected children and adults. Pediatr Res 1993;34:544-50.
12. Zon LI, Groopman JE. Hematologic manifestations of the human immunodeficiency virus (HIV). Semin Hematol 1988;25:208-18.
13. Valone FH, Payan DG, Abrams DI, Goetz EJ. Defective polymorphonuclear leukocyte chemotaxis in homosexual men with persistent lymph node syndrome. J Infect Dis 1984;150:267-71.
14. Lazzarin A, Uberti Foppa C, Galli M, Montovani A, Poli G, Franzetti F, et al. Impairment of polymorphonuclear leucocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome. Clin Exp Immunol 1986;65:105-11.
15. Nielsen H, Kharazmi A, Faber V. Blood monocyte and neutrophil functions in the acquired immunodeficiency syndrome. Scand J Immunol 1986;24:291-6.
16. Ellis M, Gupta S, Galant S, Hakim S, VandeVen C, Toy C, et al. Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. J Infect Dis 1988;158:1268-76.
17. Murphy PM, Lane HC, Fauci AS, Gallin JI. Impairment of neutrophil bactericidal capacity in patients with AIDS. J Infect Dis 1988;158:627-30.
18. Pitrak DL, Bak PM, DeMarais P, Novak RM, Andersen BR. Depressed neutrophil superoxide production in human immunodeficiency virus infection. J Infect Dis 1993;167:1406-10.
19. Elbim C, Prevot MH, Bouscarat F, Franzini E, Chollet-Martin S, Hakim J, et al. Polymorphonuclear neutrophils from human immunodeficiency virus-infected patients show enhanced activation, diminished fMLP-induced L-selectin shedding, and an impaired oxidative burst after cytokine priming. Blood 1994;84:2759-66.
20. Ryder MI, Winklee JR, Weinreib RN. Elevated phagocytosis, oxidative burst, and F-actin formation in PMNs from individuals with intraoral manifestations of HIV infection. J Acquir Immune Defic Synd 1988;1:346-53.
21. Bandreas JC, Trial J, Musher DM, Rosen RD. Increased phagocytosis and generation of reactive oxygen products by neutrophils and monocytes of men with stage 1 human immunodeficiency virus infection. J Infect Dis 1993;168:75-83.
22. Allen RC. Phagocytic leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis. Methods Enzymol 1986;133:449-93.
23. Allen RC, Stevens DL. The circulating phagocyte reflects the in vivo state of the immune system. Curr Opin Infect Dis 1992;5:389-95.
24. Chatta GS, Price TH, Allen RC, Dale DC. Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers. Blood 1994;84:2923-9.
25. Boros P, Gardos E, Bekesi GJ, Unkeless JC. Change in FcyRIII (CD 16) on neutrophils from human immunodeficiency virus-infected individuals. Clin Immunol Immunopathol 1990;54:281-9.
26. Pitrak DL, DeMarais PL, Bak PM, Novak RM, Heynen CA, Maney PJ, et al. Altered expression of neutrophil (PMNL) surface markers in AIDS. Proceedings of the Eighth International Conference on AIDS 1992; abstract PoA 2004.
27. Stevens DL, Bryant AE, Huffman J, Thompson K, Allen RC. Analysis of circulating phagocyte activity measured by whole blood luminescence: correlations with clinical status. J Infect Dis 1994;170:1463-72.
28. Guillard O, Sonnet J, Lauwerys R. Reactive oxygen species production in whole blood from AIDS patients. Clin Chim Acta 1989;185:113-4.
29. Kuijpers TW, Tool AT, van der Schoot CE, Ginsel LA, Onderwater JJ, Roos D, et al. Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood 1991;87:1105-11.
30. Ferrante A, Beard LJ, Thong YH. Early decay of human neutrophil responsiveness following isolation from peripheral blood. Clin Exp Immunol 1980;39:532-7.
31. Greenspan HC, Auroma OI. Oxidative stress and apoptosis in HIV infection: a role for plant-derived metabolites with synergistic antioxidant activity. Immunol Today 1994;15:209-13.
32. Baier-Bitterlich G, Fuchs D, Wachter H. Chronic immune stimulation, oxidative stress, and apoptosis in HIV infection. Biochem Pharmacol 1997;53:763-75.
33. Abramson JS, Mills EL. Depression of neutrophil function induced by viruses and its role in secondary microbial infections. Rev Infect Dis 1988;10:326-41.
34. Vierucci A, De Martino M, Graziani E, Rossi ME, London WT, Blumberg BS. A mechanism for liver cell injury in viral hepatitis: effects of hepatitis B virus on neutrophil function in vitro and in children with chronic active hepatitis. Pediatr Res 1983;17:814-20.
35. Witt DJ, Craven DE, McCabe WR. Bacterial infections in adult patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Am J Med 1987;82:900-6.
36. Nichols L, Balogh K, Silverman M. Bacterial infections in the acquired immune deficiency syndrome. Clinicopathologic correlations in a series of autopsy cases. Am J Clin Pathol 1989;92:787-90.
37. Kielhofner M, Atmar RL, Hamill RJ, Musher DM. Life-threatening Pseudomonas aeruginosa infections with human immunodeficiency virus infection. Clin Infect Dis 1992;14:403-11.